Given the new board member commented on our biodefense potential in the PR today, and given the company's recent announcements regarding the restart of our biodefense program, I went back and listened to the Rodman presentation from mid-September.
In that presentation, JJ indicated they would be re-establishing their biodefense program, foreshadowing the announcements we saw a few weeks later. What is interesting is what else he stated that day regarding our biodefense efforts:
"We are building a team in Washington DC and building a clinical team with other locations, right now."
It will be VERY interesting to learn what doctors/scientists and what organizations are part of our clinical team.